| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |